Importer of Controlled Substances Registration, 34879-34880 [2018-15665]
Download as PDF
<![CDATA[
34879
Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices
The company plans to import the
listed controlled substance for narcotic
material for bulk manufacture.
Dated: July 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–15750 Filed 7–20–18; 8:45 am]
BILLING CODE 4410–09–P
In accordance with 21 CFR
1301.34(a), this is notice that on April
23, 2018, Shertech Laboratories, LLC,
1185 Woods Chapel Road, Duncan
South Carolina 29334 applied to be
registered as an importer of the
following basic class of controlled
substance:
Drug
Code
Controlled substance
DEPARTMENT OF JUSTICE
Cocaine ........................
9041
Schedule
II
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Applications: Shertech Laboratories,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 22, 2018. Such persons
may also file a written request for a
hearing on the application on or before
August 22, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
amozie on DSK3GDR082PROD with NOTICES1
DATES:
VerDate Sep<11>2014
19:07 Jul 20, 2018
Jkt 244001
The company plans to import
synthetic derivatives of the listed
controlled substance in bulk form to
conduct clinical trials.
Approval of permit applications will
occur only when the registrant’s activity
is consistent with what is authorized
under to 21 U.S.C.952 (a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: July 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–15713 Filed 7–20–18; 8:45 am]
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June 5,
2018, Fisher Clinical Services, 700A–C
Nestle Way, Breinigsville, PA 18031–
1522 applied to be registered as an
importer of the following basic class of
controlled substance:
BILLING CODE 4410–09–P
Controlled substance
Drug
code
Schedule
DEPARTMENT OF JUSTICE
Psilocybin .....................
Drug Enforcement Administration
The company plans to import the
listed controlled substance for clinical
trials.
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
ACTION:
Notice of application.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
I
Dated: July 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–15667 Filed 7–20–18; 8:45 am]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 22, 2018. Such persons
may also file a written request for a
hearing on the application on or before
August 22, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
DATES:
7437
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as an importer of
various classes of schedule I or II
controlled substances.
SUPPLEMENTARY INFORMATION:
The company listed below applied to
be registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
SUMMARY:
E:\FR\FM\23JYN1.SGM
23JYN1
34880
Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices
and no requests for hearing were
submitted for this notice.
Company
FR Docket
United States Pharmacopeial Convention ..............................................
83 FR 15175 ..................................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrant to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated this company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed company.
Dated: July 12, 2018.
John J. Martin,
Assistant Administrator.
Published
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUMMARY:
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2018–15665 Filed 7–20–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Company
FR Docket
Novitium Pharma, LLC .......................................................................
Rhodes Technologies ........................................................................
Xcelience ............................................................................................
amozie on DSK3GDR082PROD with NOTICES1
April 9, 2018.
83 FR 13520 ...............................
83 FR 22517 ...............................
83 FR 22519 ...............................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrants to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: July 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–15666 Filed 7–20–18; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
19:07 Jul 20, 2018
Jkt 244001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 21, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Published
March 29, 2018.
May 15, 2018.
May 15, 2018.
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on May 31,
2018, Johnson Matthey Inc., 2003 Nolte
Drive, West Deptford, New Jersey
08066–1742 applied to be registered as
a bulk manufacturer of the following
basic class of controlled substance:
Controlled
substance
Opium tincture ......
Drug code
9630
Schedule
II
The company plans to manufacture
the above-listed controlled substance in
bulk for distribution to its customers.
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 83, Number 141 (Monday, July 23, 2018)]
[Notices]
[Pages 34879-34880]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15665]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as an
importer of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION:
The company listed below applied to be registered as an importer of
various basic classes of controlled substances. Information on the
previously published notice is listed in the table below. No comments
or objections were submitted
[[Page 34880]]
and no requests for hearing were submitted for this notice.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
United States Pharmacopeial 83 FR 15175....... April 9, 2018.
Convention.
------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of the listed registrant to import the applicable basic
classes of schedule I or II controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated this company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed company.
Dated: July 12, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-15665 Filed 7-20-18; 8:45 am]
BILLING CODE 4410-09-P
